naproxen
Generic: naproxen
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
naproxen
Generic Name
naproxen
Labeler
asclemed usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
naproxen 375 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-788
Product ID
76420-788_14060e9c-4605-5493-e063-6294a90ab6d3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212517
Listing Expiration
2026-12-31
Marketing Start
2020-03-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420788
Hyphenated Format
76420-788
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
naproxen (source: ndc)
Generic Name
naproxen (source: ndc)
Application Number
ANDA212517 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 375 mg/1
Packaging
- 1 TABLET in 1 BOTTLE (76420-788-01)
- 2 TABLET in 1 BOTTLE (76420-788-02)
- 500 TABLET in 1 BOTTLE (76420-788-05)
- 7 TABLET in 1 BOTTLE (76420-788-07)
- 100 TABLET in 1 BOTTLE (76420-788-10)
- 14 TABLET in 1 BOTTLE (76420-788-14)
- 20 TABLET in 1 BOTTLE (76420-788-20)
- 30 TABLET in 1 BOTTLE (76420-788-30)
- 60 TABLET in 1 BOTTLE (76420-788-60)
- 90 TABLET in 1 BOTTLE (76420-788-90)
Packages (10)
76420-788-01
1 TABLET in 1 BOTTLE (76420-788-01)
76420-788-02
2 TABLET in 1 BOTTLE (76420-788-02)
76420-788-05
500 TABLET in 1 BOTTLE (76420-788-05)
76420-788-07
7 TABLET in 1 BOTTLE (76420-788-07)
76420-788-10
100 TABLET in 1 BOTTLE (76420-788-10)
76420-788-14
14 TABLET in 1 BOTTLE (76420-788-14)
76420-788-20
20 TABLET in 1 BOTTLE (76420-788-20)
76420-788-30
30 TABLET in 1 BOTTLE (76420-788-30)
76420-788-60
60 TABLET in 1 BOTTLE (76420-788-60)
76420-788-90
90 TABLET in 1 BOTTLE (76420-788-90)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "14060e9c-4605-5493-e063-6294a90ab6d3", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["57Y76R9ATQ"], "rxcui": ["198012", "198013"], "spl_set_id": ["5a48c0d4-37bf-4c26-a9a7-5c67ff2adb4b"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 TABLET in 1 BOTTLE (76420-788-01)", "package_ndc": "76420-788-01", "marketing_start_date": "20240319"}, {"sample": false, "description": "2 TABLET in 1 BOTTLE (76420-788-02)", "package_ndc": "76420-788-02", "marketing_start_date": "20240319"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (76420-788-05)", "package_ndc": "76420-788-05", "marketing_start_date": "20240319"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE (76420-788-07)", "package_ndc": "76420-788-07", "marketing_start_date": "20240319"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-788-10)", "package_ndc": "76420-788-10", "marketing_start_date": "20240319"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (76420-788-14)", "package_ndc": "76420-788-14", "marketing_start_date": "20240319"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (76420-788-20)", "package_ndc": "76420-788-20", "marketing_start_date": "20240319"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-788-30)", "package_ndc": "76420-788-30", "marketing_start_date": "20240319"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-788-60)", "package_ndc": "76420-788-60", "marketing_start_date": "20240319"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-788-90)", "package_ndc": "76420-788-90", "marketing_start_date": "20240319"}], "brand_name": "Naproxen", "product_id": "76420-788_14060e9c-4605-5493-e063-6294a90ab6d3", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "76420-788", "generic_name": "Naproxen", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naproxen", "active_ingredients": [{"name": "NAPROXEN", "strength": "375 mg/1"}], "application_number": "ANDA212517", "marketing_category": "ANDA", "marketing_start_date": "20200301", "listing_expiration_date": "20261231"}